A total of 8 strains of 6 bacterial species, Porphyromonas gingivalis ATCC33277 and TDC286, Actinobacillus actinomycetemcomitans ATCC29523 and JP2, Fusobacterium nucleatum No. 2, Tannerella forsythensis ATCC43937, Prevotella intermedia ATCC25611 and Streptococcus anginosus ATCC33397, were treated with povidone-iodine (PVP-I) gargle (PVP-I: 0.47 and 0.23% w/v) or chlorhexidine gluconate (CHG) gargle (CHG: 0.002% w/v) for 15, 30 or 60 s, after which they were inoculated into various media, cultured and counted for residual bacteria. At both concentrations, PVP-I gargle reduced the viable cell count of all 8 bacterial strains to below the measurable limit within 15 s. By contrast, there were more than 1,000 viable colonies 60 s following treatment with the CHG gargle. The results demonstrate that povidone-iodine gargle has rapid bactericidal activity against the causative bacteria of periodontal disease.

1.
Hoang T, Jorgensen MG, Keim RG, Pattison AM, Slots J: Povidone-iodine as a periodontal pocket disinfectant. J Periodont Res 2003;38:311–317.
2.
Higashitsutsumi M, Kamoi K, Miyata H, Ohgi S, Shimizu T, Koide K, Nakajima S, Kojima T, Nishizawa S, Sakamoto M, Tuchiya T, Hatae S: Bactericidal effects of povidone-iodine solution to oral pathogenic bacteria in vitro. Postgrad Med J 1993;69(suppl 3):S10–S14.
3.
Kunisada T, Yamada K, Oda S, Hara O: Study of a neutralizer system for in vitro evaluation of antiseptics (in Japanese). Kankyo Kansen 1999;14:127–131.
4.
Amano A, Nakagawa I, Okahashi N, Hamada N: Variations of Porphyromonasgingivalis fimbriae in relation to microbial pathogenesis. J Periodont Res 2004;39:136–142.
5.
Haubek D, Westergaard J: 1. Detection of a highly toxic clone of Actinobacillusactinomycetemcomitans (JP2) in a Moroccan immigrant family with multiple cases of localized aggressive periodontitis. Int J Paediatr Dent 2004;14:41–48.
6.
Slots J: Update on human cytomegalovirus in destructive periodontal disease. Oral Microbiol Immunol 2004;19:217–223.
7.
Slots J: Selection of antimicrobial agents in periodontal therapy. J Periodont Res 2002;37:389–398.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.